drugset / Trial / NCT01064817
PRM-151 in the Prevention of Scarring Following Trabeculectomy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study will assess the safety and tolerability of PRM-151 administered as a subconjunctival injection and explore the effect of PRM-151 on various correlates of the wound healing process that occurs in the eye after glaucoma filtration surgery.
Timeline
- Start
- 2010-06-14
- Primary completion
- 2012-04-30
- Completion
- 2012-11-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zinpentraxin Alfa | Protein / enzyme biologic | 2 mg | Other |